Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation: A Consensus Project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMT. [electronic resource]
- JAMA oncology May 2019
- 715-722 p. digital
Publication Type: Consensus Development Conference; Journal Article
2374-2445
10.1001/jamaoncol.2018.6278 doi
Antineoplastic Agents, Immunological--therapeutic use Brentuximab Vedotin--therapeutic use Delphi Technique Female Hematopoietic Stem Cell Transplantation Hodgkin Disease--therapy Humans Lymphoma, Non-Hodgkin--therapy Maintenance Chemotherapy Male Rituximab--therapeutic use Transplantation, Autologous